Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$87.2 - $114.05 $1.92 Million - $2.51 Million
-22,041 Reduced 88.39%
2,896 $311,000
Q1 2022

Apr 07, 2022

BUY
$94.19 - $124.49 $1.47 Million - $1.94 Million
15,605 Added 167.22%
24,937 $2.77 Million
Q4 2021

Jan 10, 2022

BUY
$119.57 - $139.07 $1.12 Million - $1.3 Million
9,332 New
9,332 $1.2 Million
Q2 2019

Aug 13, 2019

SELL
$39.26 - $54.21 $43,068 - $59,468
-1,097 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$29.84 - $43.92 $32,734 - $48,180
1,097 New
1,097 $49,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bremer Bank National Association Portfolio

Follow Bremer Bank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.